IE 11 is not supported. For an optimal experience visit our site on another browser.

InoLife Technologies, Inc. Launches Ancestral Origins(TM) on Facebook

RALEIGH, N.C., May 19, 2011 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc (OTCBB:INOL), a service based healthcare products development, integration and marketing company, has announced that it has launched a Facebook page for Ancestral Origins™, its DNA-based family ancestry report product. The new page can be accessed through facebook.com./pages/ancestral-origins, the company's licensed online product sales Web site.
/ Source: GlobeNewswire

RALEIGH, N.C., May 19, 2011 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc (OTCBB:INOL), a service based healthcare products development, integration and marketing company, has announced that it has launched a Facebook page for Ancestral Origins™, its DNA-based family ancestry report product. The new page can be accessed through facebook.com./pages/ancestral-origins, the company's licensed online product sales Web site.

"Social media has dramatically transformed the way companies target and interact with their customers. We see it as a vital link for connecting us with our public and driving strong product branding through this dynamic social exchange," said Gary Berthold, President and CEO of InoLife Technologies, Inc. "As part of our initiative, we plan to support each of our DNA-based product lines throughout all of the major social media sites going forward."

InoLife affirms its confidence in the exceptional quality and accuracy of its DNA ancestry testing methodology; a process that benefits from its licensed proprietary relationship with InoHealth Products, Inc., and is backed by compiled data from scientific publications such as Forensic Science International and the Journal of Forensic Sciences.

The laboratory which processes the DNA tests is a CLIA approved human identity testing facility with accreditations from organizations such as the National Association of Testing Laboratories (NATA) and the American Association of Blood Banks (AABB). It can also add ISO 17025 certification to its credentials.

With Ancestral Origins™, individuals can compare their DNA profile against hundreds of global populations and 14 anthropological regions whose genetic information is documented and has been scientifically verified. Ancestral Origins™ calculates the likely genetic links with each of those populations and regions, and then plots the results on a large global map. The map, which is full color and suitable for framing, locates the unique geo-genetic heritage and displays both a per-population view and an overall regional view. Each Ancestral Origins™ DNA map is broken down into three major sections: Population Matches, Native Region Matches and Strength Indicators. The testing methods behind Ancestral Origins™ generate a uniquely accurate and comprehensive DNA genealogy profile.

About InoLife Technologies, Inc.

InoLife Technologies, Inc. is a pioneer in the development and marketing of state-of-the-art DNA Testing products within the U.S. The Company's mission is to aggressively identify, develop and deliver innovative and affordable healthcare products and services directly to the marketplace. By targeting cutting-edge DNA-based testing and reporting methodologies, the Company is able to significantly benefit the health and wellness needs of both individuals and their healthcare providers. 

InoLife Technologies, Inc. has developed a range of products that will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. It also offers products that are sold only to physicians, hospitals, outpatient facilities and others in the medical community for use with their patients.

Forward-Looking Statements

Safe Harbor Statement under the Private securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

CONTACT: INVESTOR RELATIONS: Steve Reiss BUZZBAHN, LLC 516-570-3850 inol@buzzbahnllc.com www.buzzbahnllc.com PUBLIC RELATIONS: Rhonda Lipschutz rlipschutz@inolifetech.com